Anlon Healthcare enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026
130—
4.44.4
24.624.6
43.743.7
194—
39.339.3
₹36.48—
298298
14.6%14.6%
0.23×—
1.13×—
4.08×—
4.22×—
−2.44×—
Reference items — trailing FY values
172172
47.547.5
46.046.0
−79.4−79.4
−79.4−79.4
−80.6−80.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AHCL₹24.47

Anlon Healthcare Limited

· Pharma & Health
₹ CrorePeersANUHPHRWANBURYBAJAJHCAREZIMLABTHEMISMEDLINCOLNSIGACHIVALIANTLABMcap ₹130 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current
last close
Market Capitalization—130.1
- Cash, Equiv & ST Investments4.44.4
+ Minority Interest24.624.6
+ Total Debt43.743.7
Enterprise Value—193.9
Net Debt (memo)39.339.3
EV per Share—36.48
Total Capital298.4298.4
Total Debt/Total Capital14.6314.63
Total Debt/EV—0.23
EV/Sales—1.13
EV/EBITDA—4.08
EV/EBIT—4.22
EV/Operating Cash Flow—-2.44
Reference Items — Trailing FY Values
Sales172.0172.0
EBITDA47.547.5
EBIT46.046.0
Operating Cash Flow-79.4-79.4
Free Cash Flow-79.4-79.4
FCFF (free cash flow to the firm)-80.6-80.6
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.